These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8342719)

  • 21. A retrospective case-control study of diseases associated with oral contraceptive use.
    Greenblatt DJ
    Am Heart J; 1975 May; 89(5):677-8. PubMed ID: 1119374
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased risk of inflammatory bowel disease associated with oral contraceptive use.
    Boyko EJ; Theis MK; Vaughan TL; Nicol-Blades B
    Am J Epidemiol; 1994 Aug; 140(3):268-78. PubMed ID: 8030630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral contraceptives on the gallbladder bile of normal women.
    Bennion LJ; Ginsberg RL; Gernick MB; Bennett PH
    N Engl J Med; 1976 Jan; 294(4):189-92. PubMed ID: 1244533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk of cholecystectomy in users of supplemental estrogen.
    Petitti DB; Sidney S; Perlman JA
    Gastroenterology; 1988 Jan; 94(1):91-5. PubMed ID: 3335303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary disease in young women and its association with pregnancy or oral contraceptives.
    Evron S; Frankel M; Diamant Y
    Int Surg; 1982; 67(4 Suppl):448-50. PubMed ID: 7183608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pill, thromboembolism, and gallbladder disease.
    Tuerck DG; Comer TP
    Lancet; 1973 Aug; 2(7824):317-8. PubMed ID: 4124790
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
    J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.
    Down RH; Whiting MJ; Watts JM; Jones W
    Gut; 1983 Mar; 24(3):253-9. PubMed ID: 6826111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity.
    Pladevall-Vila M; Delclos GL; Varas C; Guyer H; Brugués-Tarradellas J; Anglada-Arisa A
    Am J Epidemiol; 1996 Jul; 144(1):1-14. PubMed ID: 8659479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptives and non-contraceptive oestrogens in the risk of gallstone disease requiring surgery.
    La Vecchia C; Negri E; D'Avanzo B; Parazzini F; Gentile A; Franceschi S
    J Epidemiol Community Health; 1992 Jun; 46(3):234-6. PubMed ID: 1645077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cigarette smoking and parity as risk factors for the development of symptomatic gall bladder disease in women: results of the Royal College of General Practitioners' oral contraception study.
    Murray FE; Logan RF; Hannaford PC; Kay CR
    Gut; 1994 Jan; 35(1):107-11. PubMed ID: 8307429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral contraceptives: considerations of safety in nonclinical distribution.
    Atkinson L; Castadot R; Cuadros A; Rosenfield AG
    Stud Fam Plann; 1974 Aug; 5(8):242-9. PubMed ID: 4602364
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of pregnancy and contraceptive steroids on gallbladder function.
    Braverman DZ; Johnson ML; Kern F
    N Engl J Med; 1980 Feb; 302(7):362-4. PubMed ID: 7351927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined oral contraceptives: risks and benefits.
    Thorogood M; Villard-Mackintosh L
    Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk.
    Pfahlberg A; Hassan K; Wille L; Lausen B; Gefeller O
    Public Health Rev; 1997; 25(3-4):309-15. PubMed ID: 9553446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contraceptive use among women with inflammatory bowel disease: A systematic review.
    Zapata LB; Paulen ME; Cansino C; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):72-85. PubMed ID: 20682145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal stroke and use of oral contraceptives: findings from a case-control study.
    Thorogood M; Mann J; Murphy M; Vessey M
    Am J Epidemiol; 1992 Jul; 136(1):35-45. PubMed ID: 1415130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tie pill-gallbladder ills to raised cholesterol.
    Int Fam Plann Dig; 1976 Jun; 2(2):11. PubMed ID: 12334248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.